Positron Emission Tomography Scanners Market Growth Accelerated by Enhanced Cancer Detection Capabilities
The positron emission tomography (PET) scanners market involves medical imaging devices used for early and accurate cancer detection. PET scanners produce three-dimensional images of metabolic activities inside the body using radioactive tracers and are extensively used for diagnosing, staging, restaging, and monitoring cancer and other diseases.
The global Positron
Emission Tomography Scanners Market is estimated to be valued at US$ 2.5 Bn
in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2023
to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends driving the growth of the positron
emission tomography (PET) scanners market is enhanced cancer detection
capabilities. PET scanners enable precise detection and localization of cancer
at the molecular level using targeted radiotracers, which helps in early
diagnosis and treatment monitoring. They provide functional information about
tumor biology through metabolic imaging that complement structural MRI and CT
scans. This enhanced capability to non-invasively track tumor metabolism in
real-time allows oncologists to detect cancer recurrence earlier and helps
guide targeted therapy. With rising cancer prevalence globally, demand for more
sensitive diagnostic tools is increasing, thus fueling the adoption of PET
scanners in clinical settings.
Segment Analysis
The global positron emission tomography scanners market is dominated by the
hybrid PET scanners segment owing to its advantages over standalone PET
scanners such as simultaneous anatomical and functional imaging capabilities.
Hybrid PET scanners provide images of metabolic activity along with the
anatomical details, which helps physicians obtain a comprehensive view of the
disease state. Hence, hybrid PET scanners have higher adoption rates among end
users.
Key Takeaways
The global positron emission tomography scanners market is expected to witness
high growth over the forecast period of 2023 to 2030.
Key players operating in the positron emission tomography scanners market are Positron Corporation, CellSight Technologies, RefleXion, Clarity Pharmaceuticals, PETsys Electronics SA, Blue Earth Diagnostics Limited, Qubiotech Health Intelligence S.L., Advanced Accelerator Applications, Lily, Agfa-Gevaert Group, CMR Naviscan, Neusoft Corporation, Siemens, Segamicorp, ONCOVISION, MedX Holdings, Inc., Modus Medical Devices Inc., Radiology Oncology Systems, TOSHIBA CORPORATION, and General Electric Company.
Comments
Post a Comment